-
Crispr therapy is designed to attack tumors.
Researchers at the University College London have used gene editing to identify each patient’s cancer receptors and put them in immune cells without them. The edits allowed the donor T cells to slip past the body’s defenses, recognise a certain receptor on leukemia cells, and kill the cancer. The patient will receive the edited cells…
-
There were nine stark charts about how UK science is failing black researchers.
Women from minority ethnicities are less likely to get the biggest grants than their peers, because of an additional systemic bias, according to a University College London researcher. Progression up the seniority ladder relies on opaque factors, including social networks, and being vouched for by other academics, as well as access to information on grants…
-
A new study shows that the CRISPR gene-editing may boost cancer immunotherapy.
A 12-year-old boy has become the first person in the world to receive base-edited immune cells as part of a trial, the University College London said. The boy was admitted to the Great Ormond Street Hospital for Children. “There is a small amount of cells…can change my life,” he said. The boy was diagnosed with…